Blow for Medeva
Tuesday 16 May 1995
Medeva suffered a blow yesterday with the revelation that Johnson Matthey has been granted registration with the US Drug Enforcement Administration as a bulk manufacturer of its best-selling hyperactivity drug, methylphenidate. Medeva had been the only generic maker of the controlled drug, which raised sales 89 per cent to £66m last year. JM, best known as a precious metals refiner, must still gain approvals from the US Food and Drug Administration. Medeva, which is in talks with Fisons, saw its shares sink 4p to 228p.
- 3 Russian girl takes her own life after parents find pornography on her computer
- 4 Ball pool for adults opens in London
- 5 Amal Clooney gives excellent response to fashion question at European Court of Human Rights
9 reasons Greece's experiment with the radical left is doomed to failure
'We would evict Queen from Buckingham Palace and allocate her council house,' say Greens
Have we reached 'peak food'? Shortages loom as global production rates slow
Greece elections: Syriza and EU on collision course after election win for left-wing party
British grandmother Lindsay Sandiford faces execution by firing squad in Indonesia
Liberal Democrat minister defends comments suggesting immigration causes pub closures
iJobs Money & Business
£13000 per annum: Recruitment Genius: This Pension Specialist was established ...
£23000 - £26000 per annum + Benefits: Ashdown Group: Market Research Executive...
£25000 - £35000 per annum: Recruitment Genius: A Technical Report Writer is re...
Competitive salary & benefits!: MBDA UK Ltd: MBDA UK LTD Indirect Procurement...